Consolidated Statements of Income - USD ($) shares in Millions		12 Months Ended
		Dec. 31, 2016		Dec. 31, 2015	Dec. 31, 2014
Net Sales		$ 48,158,000,000		$ 48,778,000,000	$ 58,167,000,000
Cost of sales		37,641,000,000		37,836,000,000	47,464,000,000
Research and development expenses		1,584,000,000		1,598,000,000	1,647,000,000
Selling, general and administrative expenses		3,304,000,000		2,971,000,000	3,106,000,000
Amortization of intangibles		544,000,000		419,000,000	436,000,000
Goodwill and other intangible asset impairment losses		0		0	50,000,000
Restructuring charges (credits)	[1]	452,000,000		415,000,000	(3,000,000)
Asbestos-related charge		1,113,000,000	[2]	0	78,000,000	[2]
Equity in earnings of nonconsolidated affiliates		442,000,000		674,000,000	835,000,000
Sundry income (expense) - net		1,202,000,000		4,592,000,000	(27,000,000)
Interest income		107,000,000		71,000,000	51,000,000
Interest expense and amortization of debt discount		858,000,000		946,000,000	983,000,000
Income Before Income Taxes		4,413,000,000		9,930,000,000	5,265,000,000
Provision for income taxes		9,000,000		2,147,000,000	1,426,000,000
Net Income		4,404,000,000		7,783,000,000	3,839,000,000
Net income attributable to noncontrolling interests		86,000,000		98,000,000	67,000,000
Net Income Attributable to The Dow Chemical Company		4,318,000,000		7,685,000,000	3,772,000,000
Preferred stock dividends		(340,000,000)		(340,000,000)	(340,000,000)
Net Income Available for The Dow Chemical Company Common Stockholders		$ 3,978,000,000		$ 7,345,000,000	$ 3,432,000,000
Per Common Share Data:
Earnings per common share - basic (in dollars per share)		$ 3.57		$ 6.45	$ 2.91
Earnings per common share - diluted (in dollars per share)		3.52		6.15	2.87
Dividends declared per share of common stock		$ 1.84		$ 1.72	$ 1.53
Weighted-average common shares outstanding - basic		1,108.1	[3]	1,130.1	1,170.9
Weighted-average common shares outstanding - diluted		1,123.2		1,241.4	1,187.0

[1] See Note 3 for information regarding the Company's restructuring programs.

[2] See Note 15 for information regarding the asbestos-related charge.

[3] On December 30, 2016, the Company converted 4 million shares of Preferred Stock into 96.8 million shares of the Company's common stock. As a result of this conversion, 0.5 million shares of common stock are included in "Weighted-average common shares - basic" for the period ended December 31, 2016.